Liver donor macrosteatosis is associated with adverse long-term outcomes exclusively in metabolic dysfunction-associated steatotic liver disease recipients: a U.S. transplant registry analysis over the last decade.

Sierra L, Fakhoury B, Bahierathan K, Saavedra-Martinez M, Ortega Abad M, Liu L, Jahagirdar V, Danpanichkul P, Cooper KM, Diaz LA, Arab JP

Open source

DOI
10.21037/hbsn-2026-0143
Published
2026 Aug 1
Container
Hepatobiliary surgery and nutrition
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21037/hbsn-2026-0143,
  title = {Liver donor macrosteatosis is associated with adverse long-term outcomes exclusively in metabolic dysfunction-associated steatotic liver disease recipients: a U.S. transplant registry analysis over the last decade.},
  author = {Sierra L and Fakhoury B and Bahierathan K and Saavedra-Martinez M and Ortega Abad M and Liu L and Jahagirdar V and Danpanichkul P and Cooper KM and Diaz LA and Arab JP},
  year = {2026},
  journal = {Hepatobiliary surgery and nutrition},
  doi = {10.21037/hbsn-2026-0143},
  url = {https://doi.org/10.21037/hbsn-2026-0143}
}

RIS

TY  - JOUR
TI  - Liver donor macrosteatosis is associated with adverse long-term outcomes exclusively in metabolic dysfunction-associated steatotic liver disease recipients: a U.S. transplant registry analysis over the last decade.
AU  - Sierra L
AU  - Fakhoury B
AU  - Bahierathan K
AU  - Saavedra-Martinez M
AU  - Ortega Abad M
AU  - Liu L
AU  - Jahagirdar V
AU  - Danpanichkul P
AU  - Cooper KM
AU  - Diaz LA
AU  - Arab JP
PY  - 2026
JO  - Hepatobiliary surgery and nutrition
DO  - 10.21037/hbsn-2026-0143
UR  - https://doi.org/10.21037/hbsn-2026-0143
ER  - 

APA

L, S., B, F., K, B., M, S., M, O. A., L, L., V, J., P, D., KM, C., LA, D., & JP, A. (2026). Liver donor macrosteatosis is associated with adverse long-term outcomes exclusively in metabolic dysfunction-associated steatotic liver disease recipients: a U.S. transplant registry analysis over the last decade.. Hepatobiliary surgery and nutrition. https://doi.org/10.21037/hbsn-2026-0143

Source records